T
Timothy J Wilt
Researcher at University of Minnesota
Publications - 479
Citations - 41016
Timothy J Wilt is an academic researcher from University of Minnesota. The author has contributed to research in topics: Prostate cancer & Randomized controlled trial. The author has an hindex of 94, co-authored 457 publications receiving 36650 citations. Previous affiliations of Timothy J Wilt include Cochrane Collaboration & Agency for Healthcare Research and Quality.
Papers
More filters
Management of Chronic Hepatitis B
Timothy J Wilt,Tatyana Shamliyan,Aasma Shaukat,Brent C Taylor,Roderick MacDonald,Jian-Min Yuan,James R. Johnson,James Tacklind,Indulis Rutks,Robert L. Kane +9 more
TL;DR: Adverse events were common but generally mild and did not result in increased treatment discontinuation, and drugs did not reduce death, liver failure, or HCC in 16 RCTs not designed to test long-term clinical outcomes.
Journal ArticleDOI
Efficacy of newer medications for lower urinary tract symptoms attributed to benign prostatic hyperplasia: a systematic review.
Roderick MacDonald,Michelle Brasure,Philipp Dahm,Carin M Olson,Victoria A. Nelson,Howard A Fink,Michael C. Risk,Bruce Rwabasonga,Timothy J Wilt +8 more
TL;DR: Alpha-blocker silodosin and phosphodiesterase type 5 inhibitor tadalafil were more effective than placebo in improving LUTS but these drugs had more adverse effects, including abnormal ejaculation, and longer trials are needed to assess the effect of these therapies on response rates.
Journal Article
Cost savings associated with increased RN staffing in acute care hospitals
TL;DR: Policy decisions about RN staffing should include cost-utility analyses, as increased RN staffing was associated with lower hospital-related mortality and adverse patient events and generates societal net savings from avoided patient adverse events.
Journal ArticleDOI
PSA Screening for Prostate Cancer: Why Saying No is a High-Value Health Care Choice
Timothy J Wilt,Philipp Dahm +1 more
TL;DR: Until evidence supports a higher-value alternative to current PSA screening strategies, physicians should recommend against PSA Screening, policymakers should encourage reduced screening, and most men should say no to the PSA test.
Journal Article
Long-Term Drug Therapy and Drug Discontinuations and Holidays for Osteoporosis Fracture Prevention
Howard A Fink,Roderick MacDonald,Mary L Forte,Christina E. Rosebush,Kristine E. Ensrud,John T. Schousboe,Victoria A. Nelson,Kristen Ullman,Mary Butler,Carin M Olson,Brent C Taylor,Michelle Brasure,Timothy J Wilt +12 more
TL;DR: In this article, a systematic review of 48 studies examines the benefits and harms of long-term drug treatment for osteoporosis, as well as the benefits of treatment discontinuation and holidays.